(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 8.44% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Edwards Lifesciences's revenue in 2024 is $6,143,400,000.On average, 12 Wall Street analysts forecast EW's revenue for 2024 to be $3,949,950,760,000, with the lowest EW revenue forecast at $3,924,997,860,000, and the highest EW revenue forecast at $3,972,598,000,000. On average, 12 Wall Street analysts forecast EW's revenue for 2025 to be $4,324,717,432,000, with the lowest EW revenue forecast at $4,269,986,000,000, and the highest EW revenue forecast at $4,396,406,000,000.
In 2026, EW is forecast to generate $4,721,573,892,000 in revenue, with the lowest revenue forecast at $4,622,156,000,000 and the highest revenue forecast at $4,852,722,000,000.